 Nidhya Navanandan
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 16 | 2025 | 1795 | 4.410 |
Why?
| | Anti-Asthmatic Agents | 5 | 2024 | 260 | 1.860 |
Why?
| | Oscillometry | 2 | 2025 | 35 | 1.540 |
Why?
| | Adrenal Cortex Hormones | 6 | 2025 | 483 | 1.390 |
Why?
| | Emergency Service, Hospital | 14 | 2025 | 2377 | 1.350 |
Why?
| | Pneumonia | 7 | 2023 | 635 | 1.240 |
Why?
| | Bronchodilator Agents | 4 | 2025 | 187 | 1.200 |
Why?
| | Respiratory Sounds | 2 | 2024 | 103 | 0.980 |
Why?
| | Respiratory Tract Infections | 4 | 2024 | 394 | 0.970 |
Why?
| | Airway Resistance | 2 | 2025 | 38 | 0.860 |
Why?
| | Severity of Illness Index | 5 | 2025 | 2928 | 0.810 |
Why?
| | Community-Acquired Infections | 5 | 2023 | 177 | 0.800 |
Why?
| | Recurrence | 2 | 2024 | 1134 | 0.800 |
Why?
| | Child | 28 | 2025 | 22670 | 0.800 |
Why?
| | Virus Diseases | 2 | 2023 | 216 | 0.720 |
Why?
| | Child, Preschool | 15 | 2025 | 11835 | 0.620 |
Why?
| | Medicaid | 1 | 2024 | 466 | 0.600 |
Why?
| | Staphylococcus aureus | 1 | 2023 | 451 | 0.590 |
Why?
| | Glucocorticoids | 2 | 2020 | 531 | 0.540 |
Why?
| | Physicians, Primary Care | 1 | 2020 | 208 | 0.510 |
Why?
| | Patient Discharge Summaries | 1 | 2017 | 10 | 0.510 |
Why?
| | Biomedical Research | 1 | 2023 | 717 | 0.490 |
Why?
| | Dexamethasone | 4 | 2025 | 365 | 0.490 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 241 | 0.480 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 115 | 0.470 |
Why?
| | Prospective Studies | 11 | 2025 | 8035 | 0.450 |
Why?
| | Health Literacy | 1 | 2017 | 184 | 0.420 |
Why?
| | Prednisone | 3 | 2020 | 221 | 0.410 |
Why?
| | Emergency Medical Services | 2 | 2021 | 684 | 0.400 |
Why?
| | Physicians | 1 | 2022 | 954 | 0.400 |
Why?
| | Humans | 30 | 2025 | 145140 | 0.360 |
Why?
| | Acute Disease | 4 | 2024 | 1035 | 0.350 |
Why?
| | Patient Readmission | 1 | 2017 | 769 | 0.330 |
Why?
| | Prednisolone | 2 | 2020 | 67 | 0.310 |
Why?
| | Male | 16 | 2025 | 72664 | 0.280 |
Why?
| | Caregivers | 1 | 2017 | 1070 | 0.270 |
Why?
| | ROC Curve | 2 | 2025 | 617 | 0.240 |
Why?
| | Patient Discharge | 3 | 2024 | 991 | 0.230 |
Why?
| | Female | 14 | 2025 | 78636 | 0.220 |
Why?
| | Disease Progression | 2 | 2024 | 2857 | 0.220 |
Why?
| | Infant | 7 | 2024 | 10060 | 0.210 |
Why?
| | Rhinovirus | 1 | 2024 | 60 | 0.210 |
Why?
| | Hospitalization | 4 | 2022 | 2458 | 0.210 |
Why?
| | Adolescent | 7 | 2025 | 22479 | 0.200 |
Why?
| | Picornaviridae Infections | 1 | 2024 | 53 | 0.200 |
Why?
| | Risk Factors | 4 | 2024 | 10857 | 0.200 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 543 | 0.200 |
Why?
| | Enterotoxins | 1 | 2023 | 89 | 0.200 |
Why?
| | Quality of Life | 4 | 2024 | 3194 | 0.190 |
Why?
| | Bronchiolitis | 1 | 2024 | 87 | 0.190 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 81 | 0.180 |
Why?
| | Albuterol | 2 | 2025 | 76 | 0.180 |
Why?
| | Educational Status | 1 | 2024 | 465 | 0.170 |
Why?
| | Magnesium | 1 | 2022 | 156 | 0.170 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 139 | 0.170 |
Why?
| | Administration, Intravenous | 1 | 2022 | 171 | 0.170 |
Why?
| | Viruses | 1 | 2023 | 164 | 0.170 |
Why?
| | Delphi Technique | 1 | 2023 | 330 | 0.170 |
Why?
| | Dyspnea | 1 | 2023 | 250 | 0.160 |
Why?
| | Schools | 1 | 2024 | 448 | 0.160 |
Why?
| | Consensus | 1 | 2023 | 478 | 0.160 |
Why?
| | Allergens | 1 | 2023 | 386 | 0.160 |
Why?
| | Drug Monitoring | 1 | 2024 | 399 | 0.160 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 6055 | 0.150 |
Why?
| | Thrombectomy | 1 | 2019 | 78 | 0.140 |
Why?
| | Vena Cava Filters | 1 | 2019 | 64 | 0.140 |
Why?
| | Self Report | 1 | 2022 | 867 | 0.130 |
Why?
| | Administration, Oral | 1 | 2020 | 862 | 0.130 |
Why?
| | Ipratropium | 1 | 2017 | 4 | 0.130 |
Why?
| | Retrospective Studies | 4 | 2025 | 17247 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2024 | 6435 | 0.130 |
Why?
| | Influenza, Human | 1 | 2023 | 624 | 0.130 |
Why?
| | Nebulizers and Vaporizers | 1 | 2017 | 62 | 0.120 |
Why?
| | Single-Blind Method | 1 | 2017 | 316 | 0.120 |
Why?
| | Sepsis | 1 | 2022 | 662 | 0.120 |
Why?
| | Feasibility Studies | 1 | 2020 | 1109 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 195 | 0.110 |
Why?
| | Phenotype | 1 | 2023 | 3138 | 0.110 |
Why?
| | Health Surveys | 1 | 2017 | 517 | 0.110 |
Why?
| | Prognosis | 1 | 2023 | 4310 | 0.100 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1264 | 0.100 |
Why?
| | Anticoagulants | 1 | 2019 | 748 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 708 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2024 | 11741 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2017 | 608 | 0.090 |
Why?
| | United States | 3 | 2025 | 16065 | 0.090 |
Why?
| | Biomarkers | 1 | 2023 | 4282 | 0.090 |
Why?
| | Primary Health Care | 1 | 2020 | 1725 | 0.080 |
Why?
| | Pediatrics | 1 | 2017 | 1121 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1415 | 0.070 |
Why?
| | Adult | 2 | 2020 | 40665 | 0.050 |
Why?
| | Uncertainty | 1 | 2024 | 145 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 360 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 48 | 0.050 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1922 | 0.040 |
Why?
| | Fever | 1 | 2022 | 318 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 222 | 0.040 |
Why?
| | Epinephrine | 1 | 2021 | 158 | 0.040 |
Why?
| | Young Adult | 1 | 2017 | 14176 | 0.040 |
Why?
| | Fatigue | 1 | 2022 | 363 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1082 | 0.040 |
Why?
| | Pneumonia, Viral | 1 | 2024 | 388 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 557 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 36126 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 2767 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5411 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5988 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4101 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5886 | 0.020 |
Why?
|
|
Navanandan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|